Koyfin Home > Directory > Health Care > Abbott Laboratories > EBITDA / Interest Expenses

Abbott Laboratories EBITDA / Interest Expenses Chart (ABT)

Abbott Laboratories annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Abbott Laboratories EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $16m a 14.15% increase of 2m year over year
  • Abbott Laboratories EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $14m a 9.95% increase of 1m year over year
  • Abbott Laboratories Annual EBITDA / Interest Expenses for 2019 was $12m a 28.98% increase of 4m from 2018
  • Abbott Laboratories Annual EBITDA / Interest Expenses for 2018 was $9m a 24.40% increase of 2m from 2017
  • Abbott Laboratories Annual EBITDA / Interest Expenses for 2017 was $7m a -60.87% decrease of -4m from 2016
Other Ratios Metrics:
  • Abbott Laboratories Total Debt / Capital for the quarter ending December 12, 2018 was $44m a 5.51% increase of 2m year over year
  • Abbott Laboratories Other Liabilities for the quarter ending September 09, 2018 was $8,407m a -7.41% decrease of -623m year over year
  • Abbott Laboratories Total Debt / Equity for the quarter ending December 12, 2018 was $77m a 9.36% increase of 7m year over year
View Chart On Koyfin

Quarterly ABT EBITDA / Interest Expenses Data

09/2020$16m
06/2020$12m
03/2020$12m
12/2019$14m
09/2019$12m
06/2019$12m
03/2019$9m
12/2018$11m
09/2018$9m
06/2018$8m

Annual ABT EBITDA / Interest Expenses Data

2019$12m
2018$9m
2017$7m
2016$11m
2015$27m
2014$29m
2013$27m
2012$13m
2011$13m
2010$17m